Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Understanding Successful Compromise Standards to Cultivate Agreeable Connections - 26 Solid Moving Administrations for a Calm Movement
- 3This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths
- 4Russia Fields New Ulan-2 All-Terrain Tactical Vehicle
- 5Israel says soldiers wounded in Gaza fighting amid fragile truce
- Spain and Catholic Church agree to compensate sex abuse victims
- Palestine weekly wrap: Protests sweep West Bank after death penalty law
- $30K Disability Scam Implodes After Surf Trip in Mexico
- 4 Sound blocking Earphones for Prevalent Sound and Solace
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- NASA astronauts take new moonsuit for a swim | Space photo of the day for Nov. 28, 2025
- Iran, Hezbollah fire rockets at Israel during Passover celebrations
- Major Scottish gangland figure Steven Lyons arrested in Bali
- Uranus's small moons are dark, red, and water-poor
